PURLs

Updated USPSTF screening guidelines may reduce lung cancer deaths

Author and Disclosure Information

By nearly doubling the number of patients eligible for screening, as many as 60,000 US lives may be saved—but concerns may limit acceptance.

PRACTICE CHANGER

Start assessing risk and screening for lung cancer at age 50 in patients who have a 20-pack-year history of smoking, using low-dose computed tomography (LDCT) scanning. This practice, based on a 2020 US Preventive Services Task Force (USPSTF) guideline update, is expected to reduce annual mortality from lung cancer by an additional 3% or more (from 9.8% to 13%).

STRENGTH OF RECOMMENDATION

A: Evidence-based clinical practice guideline1

US Preventive Services Task Force. Lung cancer: screening. Final recommendation statement. March 9, 2021. Accessed August 19, 2021. https://uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening


 

References

ILLUSTRATIVE CASE

A 50-year-old woman presents to your office for a well-woman exam. Her past medical history includes a 22-pack-year smoking history (she quit 5 years ago), well-controlled hypertension, and mild obesity. She has no family history of cancer, but she does have a family history of type 2 diabetes and heart disease. Besides age- and risk-appropriate laboratory tests, cervical cancer screening, breast cancer screening, and initial colon cancer screening, are there any other preventive services you would offer her?

Lung cancer is the second most common cancer in both men and women, and it is the leading cause of cancer death in the United States—regardless of gender. The American Cancer Society estimates that 235,760 people will be diagnosed with lung cancer and 131,880 people will die of the disease in 2021.2

In the 2015 National Cancer Institute report on the economic costs of cancer, direct and indirect costs of lung cancer totaled $21.1 billion annually. Lost productivity from lung cancer added another $36.1 billion in annual costs.3 The economic costs increased to $23.8 billion in 2020, with no data on lost productivity.4

Smoking tobacco is by far the primary risk factor for lung cancer, and it is estimated to account for 90% of all lung cancer cases. Compared with nonsmokers, the relative risk of lung cancer is approximately 20 times higher for smokers.5,6

Because the median age of lung cancer diagnosis is 70 years, increasing age is also considered a risk factor for lung cancer.2,7

Although lung cancer has a relatively poor prognosis—with an average 5-year survival rate of 20.5%—early-stage lung cancer is more amenable to treatment and has a better prognosis (as is true with many cancers).1

LDCT has a high sensitivity, as well as a reasonable specificity, for lung cancer detection. There is demonstrated benefit in screening patients who are at high risk for lung cancer.8-11 In 2013, the USPSTF recommended annual lung cancer screening (B recommendation) with LDCT in adults 55 to 80 years of age who have a 30-pack-year smoking history, and who currently smoke or quit within the past 15 years.1

Continue to: STUDY SUMMARY

Pages

Copyright © 2021. The Family Physicians Inquiries Network. All rights reserved.

Next Article: